C the Signs is using AI to sharpen predictions on cancer risk.

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of ...

DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it benefit the world?

Artificial intelligence is able to identify women who have an elevated risk of developing breast cancer several years before it is diagnosed, the Norwegian Institute of Public Health (FHI) said on ...

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

ORNL's AI reduces cancer report processing time from 22 to 14 months, aiding faster cancer trend identification.

AI’s role in oncology is expanding rapidly, offering new ways to detect, treat, and manage cancer. By analyzing large datasets, AI can uncover patterns and insights that are difficult for humans to ...

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

Invest in Nvidia Corporation as AI spending surges. Recent dip offers a buying opportunity. Read my in-depth look at NVDA stock and its growing opportunities.

The future of oncology lies in people-centered care, prioritizing patient needs and leveraging technology to improve cancer treatment and support systems.